How plausible may be a conference on IP (and regulatory) exclusivity? Sufficiently By Gabriele Girardello on Monday, November 14, 2022 #economics #UPC biotech and pharmaceutical conference clinical trial data data and market exclusivity Gabriele Girardello patent exclusivity regulatory data second medical indication SPC +
On economic analysis of IP law: an interview with professor Tom Cotter By Léon Dijkman on Friday, August 30, 2019 #economics #interview #IPKat +